Stock fact sheet · data as of

Fidelity Health Savings Fund Class K (FHLKX): fair value, margin of safety and Wheel Score

Financial Services · Asset Management · United States · Blend

Close11.49
GLS fair value1,202.582 of 9 models
Margin of safety+99%price below fair value
Wheel Score39No optionscapped: no options
Health8/9Piotroski F-score
Moat3.4/10GLS 10-year score
Market cap$72M
Implied vol.-no listed options
P/E-EPS 0.00
Dividend yield3.91%payout 35%
Beta0.72moves less than the market
Next earnings-no date recorded

Is FHLKX undervalued?

FHLKX has a margin of safety of 99%: the stock closed at 11.49 on 16 Oct 2026 against a GLS average fair value of 1,202.58. 1 of the 2 valuation models that produced a number sit above the price. Our screens treat a discount this large as a strong starting point for a cash-secured put, not as a verdict - the fair value is a model output, and a wide gap can mean the models are missing something the market knows.

The average is built from just 2 models (10 Cap, DDM) - the rest returned nothing because an input they need (dividends, free cash flow, book value) is zero or negative - so treat it with more caution than usual.

The nightly engine files FHLKX under Blend.

Nine valuation models for FHLKX

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF--Present value of the projected free cash flows, discounted at the cost of capital; no value tonight
Graham Number--The most a defensive investor pays for the earnings and book value per share; no value tonight
Graham Growth--Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight
Lynch--EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight
GLS Growth--EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight
10 Cap2,398.56+20775%Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%
Payback Time--Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight
DDM6.61-43%Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend
EPV--Earnings power value: current EPS capitalised at 9% with no growth; no value tonight
Zombie (liquidation)-405.03-3625%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target0.0000-100%Analysts' average 12-month price target. Not in the average

Quality and financial health

Fidelity Health Savings Fund Class K scores 8 of 9 on the Piotroski F-score, the nine yes/no tests of profitability, leverage and efficiency on the latest annual accounts - a strong reading that passes the Sunday Scan's "6 or more" rule with room to spare. A GLS Moat score of 3.4/10 is a weak reading: the ten-year history the score grades (revenue, EPS, book value, margins, cash flow, share count, ROIC) has not been steady, so the Moat part of the Wheel Score contributes little.

Returns on capital are thin or negative - ROIC 5.0%, ROE 6.8%, ROA 3.9% - with debt at 0.37 times equity and a free-cash-flow yield of 542.0%.

The dividend yield is 3.91% at a payout ratio of 35%; for a wheel trader holding assigned shares the dividend adds to the covered-call premium, and the ex-dividend date is worth knowing before a call is sold.

Institutional ownership scores 5/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score8 / 9ROIC5.0%
GLS Moat3.4 / 10ROE6.8%
Debt / equity0.37ROA3.9%
Free-cash-flow yield542.0%Payout ratio35%
Institutions5 / 10Insiders · Congress5 · 5 / 10

Wheel Score 39: No options

No options are listed on Fidelity Health Savings Fund Class K in our nightly snapshot. The Wheel Score is therefore capped at 39 (it reads 39) and the stock is left out of every options screen; the fair value and health figures above are still useful for a plain stock position.

Volume runs at - a day on a market cap of $72M, with a beta of 0.72 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 6 of 20.

PartPointsFrom
Value25 / 2599% margin of safety
Health18 / 20Piotroski 8/9
Moat5 / 15moat 3.4/10
Premium0 / 20no option data
Stability6 / 200k shares/day, $72M cap, beta 0.72

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

No upcoming earnings date is recorded for FHLKX in the nightly calendar.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Asset Management

The 12 companies below are the closest to Fidelity Health Savings Fund Class K by market cap within the Asset Management industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
ZSTK
ZeroStack Corp.
4.15--21No options$72M
GLV
Clough Global Dividend and Income Fund
5.7845.38+87%39No options$72M
VGI
Virtus Global Multi-Sector Income Fund
6.5425.03+74%39No options$74M
SWZ
Total Return Securities Fund
5.7210.34+45%39No options$74M
GECCH
Great Elm Capital Corp. - 8.125
24.9257.34+57%39No options$70M
BSVSX
Baird Equity Opportunity Fund - Investor Class
14.57784.60+98%39No options$70M
EEA
The European Equity Fund, Inc.
10.2450.36+80%39No options$70M
PCL
PGIM ETF Trust - PGIM Corporate Bond 10+ Year ETF
45.6522.68-101%23No options$70M
GECC
Great Elm Capital Corp.
5.0255.69+91%39No options$70M
AFCG
Advanced Flower Capital Inc.
3.104.69+34%43Weak$70M
SVRN
SVRN, Inc.
36.51--26No options$68M
UNOV
Innovator U.S. Equity Ultra Buffer ETF
41.640.1397-29706%27No options$78M

⚖ Compare FHLKX with 7 of them   All Financial Services stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about FHLKX

Is FHLKX undervalued right now?

By the GLS models, yes: at 11.49 the stock is 99% below the average fair value of 1,202.58 (data as of 16 Oct 2026). Whether the discount is deserved is the question to research next.

What is the Wheel Score of FHLKX and what does it mean?

FHLKX has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".

What is the GLS fair value for FHLKX?

1,202.58 per share as of 16 Oct 2026 - the simple average of the 2 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does Fidelity Health Savings Fund Class K report earnings next?

No upcoming earnings date is recorded for FHLKX in our calendar as of 16 Oct 2026; the Calendars page is refreshed every morning.

Does FHLKX have listed options, and how liquid are they?

No. The nightly options snapshot found no listed contracts on FHLKX, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.